Southpoint Capital Advisors LP - 24 Dec 2025 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Reporting relationship: 10%+ Owner
Issuer ticker: FENC
Reported as of: 24 Dec 2025
Net transaction value: -$7,500,000
SEC form: 4
Accepted by SEC: 29 Dec 2025, 16:34:30 UTC
Prior SEC filing: 20 Nov 2025
Source filing: View source filing
Reporting owner signature: s/ John S. Clark II, Southpoint Capital Advisors LP, by Southpoint Capital Advisors LLC, its General Partner, by John S. Clark II, Managing Member

Key filing fact

Southpoint Capital Advisors LP filed Form 4 for FENNEC PHARMACEUTICALS INC. (FENC) on 29 Dec 2025.

Key facts

This page summarizes Southpoint Capital Advisors LP's Form 4 filing for FENNEC PHARMACEUTICALS INC. (FENC).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 29 Dec 2025, 16:34.

Change

Previous filing in this sequence was filed on 20 Nov 2025.
Current net transaction value: -$7,500,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (5)

CIK 0001319998 Primary reporting owner

Southpoint Capital Advisors LP

Relationship: 10%+ Owner
Address: 1114 AVENUE OF THE AMERICAS, 22ND FLOOR, NEW YORK
Signature: s/ John S. Clark II, Southpoint Capital Advisors LP, by Southpoint Capital Advisors LLC, its General Partner, by John S. Clark II, Managing Member
Signature date: 29 Dec 2025

CIK 0001378377

Southpoint Capital Advisors LLC

Relationship: 10%+ Owner
Address: 1114 AVENUE OF THE AMERICAS, 22ND FLOOR, NEW YORK
Signature: /s/ John S. Clark II, Southpoint Capital Advisors LLC, by John S. Clark II, Managing Member
Signature date: 29 Dec 2025

CIK 0001378376

Southpoint GP, LP

Relationship: 10%+ Owner
Address: 1114 AVENUE OF THE AMERICAS, 22ND FLOOR, NEW YORK
Signature: /s/ John S. Clark II, Southpoint GP, LP, by Southpoint GP, LLC, its General Partner, by John S. Clark II, Managing Member
Signature date: 29 Dec 2025

CIK 0001378378

Southpoint GP, LLC

Relationship: 10%+ Owner
Address: 1114 AVENUE OF THE AMERICAS, 22ND FLOOR, NEW YORK
Signature: /s/ John S. Clark II, Southpoint GP, LLC, by John S. Clark II, Managing Member
Signature date: 29 Dec 2025

CIK 0001378379

Clark John Smith II

Relationship: 10%+ Owner
Address: 1114 AVENUE OF THE AMERICAS, 22ND FLOOR, NEW YORK
Signature: /s/ John S. Clark II
Signature date: 29 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

FENC transaction

Common Stock

Sale

Transaction value: $7,500,000
Shares: -1,000,000
Change %: -27%
Price: $7.50
Shares after: 2,744,741
Date: 24 Dec 2025
Ownership: See Footnote
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The securities are directly held by Southpoint Master Fund, LP for which Southpoint Capital Advisors LP serves as the investment manager and Southpoint GP, LP serves as the general partner. Southpoint Capital Advisors LLC serves as the general partner of Southpoint Capital Advisors LP and Southpoint GP, LLC serves as the general partner of Southpoint GP, LP. John S. Clark II serves as managing member of both Southpoint Capital Advisors LLC and Southpoint GP, LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or his pecuniary interest therein.